CN107151638A - One plant improvement liver function Lactobacillus plantarum ZY001 and its application in acidified milk - Google Patents
One plant improvement liver function Lactobacillus plantarum ZY001 and its application in acidified milk Download PDFInfo
- Publication number
- CN107151638A CN107151638A CN201710376089.5A CN201710376089A CN107151638A CN 107151638 A CN107151638 A CN 107151638A CN 201710376089 A CN201710376089 A CN 201710376089A CN 107151638 A CN107151638 A CN 107151638A
- Authority
- CN
- China
- Prior art keywords
- milk
- lactobacillus plantarum
- donkey
- culture
- lactobacillus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 240000006024 Lactobacillus plantarum Species 0.000 title claims abstract description 45
- 235000013965 Lactobacillus plantarum Nutrition 0.000 title claims abstract description 41
- 229940072205 lactobacillus plantarum Drugs 0.000 title claims abstract description 41
- 235000020167 acidified milk Nutrition 0.000 title claims abstract description 18
- 230000003908 liver function Effects 0.000 title claims abstract description 12
- 230000006872 improvement Effects 0.000 title claims description 8
- 235000020250 donkey milk Nutrition 0.000 claims abstract description 32
- 235000013336 milk Nutrition 0.000 claims abstract description 25
- 210000004080 milk Anatomy 0.000 claims abstract description 25
- 239000008267 milk Substances 0.000 claims abstract description 23
- 230000000694 effects Effects 0.000 claims abstract description 11
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 241000194020 Streptococcus thermophilus Species 0.000 claims abstract description 6
- 244000005700 microbiome Species 0.000 claims abstract description 4
- 241000894006 Bacteria Species 0.000 claims description 21
- 238000000855 fermentation Methods 0.000 claims description 19
- 230000004151 fermentation Effects 0.000 claims description 19
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 12
- 230000001580 bacterial effect Effects 0.000 claims description 7
- 239000002054 inoculum Substances 0.000 claims description 7
- 239000012530 fluid Substances 0.000 claims description 6
- 235000014655 lactic acid Nutrition 0.000 claims description 6
- 239000004310 lactic acid Substances 0.000 claims description 6
- 235000015097 nutrients Nutrition 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 4
- 238000004321 preservation Methods 0.000 claims description 3
- 238000011160 research Methods 0.000 claims description 2
- 241001608472 Bifidobacterium longum Species 0.000 claims 1
- 241000186673 Lactobacillus delbrueckii Species 0.000 claims 1
- 241000186605 Lactobacillus paracasei Species 0.000 claims 1
- 229940009291 bifidobacterium longum Drugs 0.000 claims 1
- 235000020248 camel milk Nutrition 0.000 claims 1
- 238000001816 cooling Methods 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 235000020251 goat milk Nutrition 0.000 claims 1
- 239000001963 growth medium Substances 0.000 claims 1
- 239000002609 medium Substances 0.000 claims 1
- 235000020183 skimmed milk Nutrition 0.000 claims 1
- 241000283074 Equus asinus Species 0.000 abstract description 8
- 235000013618 yogurt Nutrition 0.000 abstract description 5
- 238000005516 engineering process Methods 0.000 abstract description 4
- 230000000813 microbial effect Effects 0.000 abstract description 3
- 238000002156 mixing Methods 0.000 description 9
- 210000000481 breast Anatomy 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 7
- 241000700159 Rattus Species 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000003304 gavage Methods 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- -1 L- sorboses Chemical compound 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 231100000753 hepatic injury Toxicity 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 3
- 108010082126 Alanine transaminase Proteins 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 230000001476 alcoholic effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000021001 fermented dairy product Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 101150080777 pheS gene Proteins 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 108020004465 16S ribosomal RNA Proteins 0.000 description 2
- AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 102000016938 Catalase Human genes 0.000 description 2
- 108010053835 Catalase Proteins 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N D-Maltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- 206010067125 Liver injury Diseases 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical class [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 239000005862 Whey Substances 0.000 description 2
- 102000007544 Whey Proteins Human genes 0.000 description 2
- 108010046377 Whey Proteins Proteins 0.000 description 2
- PQLVXDKIJBQVDF-UHFFFAOYSA-N acetic acid;hydrate Chemical compound O.CC(O)=O PQLVXDKIJBQVDF-UHFFFAOYSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical class CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 229940066779 peptones Drugs 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 230000004224 protection Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000176 sodium gluconate Substances 0.000 description 2
- 235000012207 sodium gluconate Nutrition 0.000 description 2
- 229940005574 sodium gluconate Drugs 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 244000185256 Lactobacillus plantarum WCFS1 Species 0.000 description 1
- 235000011227 Lactobacillus plantarum WCFS1 Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010053159 Organ failure Diseases 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 235000014590 basal diet Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- DLRVVLDZNNYCBX-ZZFZYMBESA-N beta-melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 DLRVVLDZNNYCBX-ZZFZYMBESA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid group Chemical class C(CC(O)(C(=O)O)CC(=O)O)(=O)O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 235000014048 cultured milk product Nutrition 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 210000001842 enterocyte Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 235000021262 sour milk Nutrition 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1238—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt using specific L. bulgaricus or S. thermophilus microorganisms; using entrapped or encapsulated yoghurt bacteria; Physical or chemical treatment of L. bulgaricus or S. thermophilus cultures; Fermentation only with L. bulgaricus or only with S. thermophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/249—Thermophilus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/25—Lactobacillus plantarum
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Dairy Products (AREA)
Abstract
The invention discloses one plant of Lactobacillus plantarum (lactobacillus plantarum, L.plantarum) ZY001 for improving liver function and its application in acidified milk, belong to microbial technology field.The isolated Lactobacillus plantarum ZY001 from the traditional donkey Yoghourt in Xinjiang, is preserved in China Committee for Culture Collection of Microorganisms's common micro-organisms center, culture presevation CGMCC 13505.Using Lactobacillus plantarum ZY001, it is used alone or with Lactobacillus rhamnosus, streptococcus thermophilus with 13: 12: 1 proportioning, with donkey milk: milk=2 4: 86 are that fermenting raw materials prepare donkey milk acidified milk.Lactobacillus plantarum ZY001 disclosed by the invention possesses the effect for improving liver function.
Description
Technical field
The invention belongs to microbial technology field.More particularly it relates to the newborn bar of the plant of one plant of improvement liver function
Bacterium (lactobacillus plantarum, L.plantarum) ZY001 and its application in acidified milk.
Background technology
Kashi Area of Xingjiang Autonomous Region has superior grass resource condition and the abundant stalk resource of planting industry, possesses donkey kind, number
Resources advantage is measured, is that donkey industry development creates advantageous condition.2008, Xinjiang Donkey was listed in national Application of Animal Genetic
Protection of resources kind.
Donkey milk is as one of principal by product of donkey aquaculture, not only with higher nutritive value, and with wider
General medical value.Other milk supplies are compared, and donkey milk is the day of a kind of low fat, low cholesterol, high calcium, selenium-rich, beauty, anti-aging
The closest human milk of ratio of each nutritional ingredient in right dairy products, donkey milk.Contain substantial amounts of epithelical cell growth factor in donkey milk
(EGF), EGF can strengthen the immunity of human body, resistance；Epithelial cell Nutrition and Metabolism, protection skin and prevention skin can be promoted
Skin has promotion subcutaneous collagen cytothesis function due to being lost caused by a variety of causes.
Domestic and international clinical research shows that the reversible intestinal flora of probiotic lactobacillus is unbalance, when intestinal submucosal tissue is impaired tight
Weight, special dietary material of the increase rich in reparation enterocyte, such as polysaccharide prebiotics, integration of drinking and medicinal herbs function ingredients etc., it is right
Recovering function of intestinal canal has definite gain effect, can reduce enterogenic infection and the incidence of organ failure, is to reverse disease
The key link of acute turn of danger of disease, so as to reduce case fatality rate；Use and the hospital stays of antibiotic can be reduced simultaneously, reduction medical treatment
Expense, Tiny ecosystem nutrition treatment opens one for disease treatment and fans new window.
Lactobacillus plantarum is one kind of lactic acid bacteria, is normally present in the vegetables and fruit juice of fermentation, food, ensilage and
The fields such as health care are received more and more attention.The bacterial strain belongs to homofermentative lactic bacteria, can utilize glucose, malt
Sugar, sucrose, L- sorboses, lactose, cellobiose, xylose, melibiose, fructose, ribose, sodium gluconate production acid, but fermentation Portugal
Grape sugar and sodium gluconate not aerogenesis.During using strain fermentation lactose production acid treatment Lactose in Whey conversion, with other
The incomparable superiority of strain, it both can be in high conversion rate glucose using Lactose conversion, can utilize again in whey
Residual protein.
The present invention characteristic be：1st, strain source is isolated from the local method donkey Yoghourt of Xinjiang in Kashi Area of Xingjiang Autonomous Region
Lactic acid bacteria；2nd, Lactobacillus plantarum, with intestinal flora balance is maintained, improves body and exempted from as the beneficial flora in human body intestinal canal
A variety of functions such as epidemic disease power and improvement liver function；3rd, the products scheme that the A of CN 104770469 are provided is with pure donkey milk or adds other
The donkey milk of the natural extracts aqueous solution of casein containing protein is not that fermenting raw materials produce sour milk product, wherein due to donkey milk junket egg
The reason for Bai Hanliang is low can not realize the preparation of Yoghourt, can be classified as one kind of lactic acid drink.The present invention Yoghourt preparation process be
Fermentation kind is prepared with 1~3: 1~2: 1 proportioning with Lactobacillus plantarum or Lactobacillus plantarum, Lactobacillus rhamnosus, streptococcus thermophilus
Son, is seeded to donkey milk: milk=2~4: in 8~6 mixing dairy milk starting material, fermentation obtains curds type donkey milk fermented dairy product.
The content of the invention
[technical problem to be solved]
It is an object of the invention to provide one plant improvement liver function Lactobacillus plantarum (lactobacillus plantarum,
L.plantarum)ZY001。
It is a further object to provide applications of the described Lactobacillus plantarum ZY001 in acidified milk.
[technical scheme]
The present invention is achieved through the following technical solutions.
The present invention relates to a lactobacillus plantarum ZY001, the bacterial strain is on 09 02nd, 2016 in Chaoyang District, Beijing City
No. 3 China Committee for Culture Collection of Microorganisms's common micro-organisms center's preservations of the institute of North Star West Road 1, preserving number is respectively
CGMCC 13505。
A preferred embodiment of the invention, described newborn class fermented product is acidified milk.
It is prepared by a preferred embodiment of the invention, Lactobacillus plantarum ZY001 and its application in acidified milk
Step is as follows：
(1) the isolated lactic acid bacteria ZY001 from the local method donkey Yoghourt of Xinjiang, identified is Lactobacillus plantarum, i.e. plant breast
Bacillus ZY001；
(2) with donkey milk and milk mixing breast for raw material, inoculated plant lactobacillus ZY001 fermentations obtain the fermentation of single bacterium donkey milk
Breast；
(3) with single bacterium donkey milk acidified milk gavage alcoholic hepatic injury SD rats, glutamic-oxalacetic transaminease (AST) and third turn of ammonia of paddy are determined
Enzyme (ALT) content, determines that Lactobacillus plantarum ZY001 improves effect of liver function；
(4) Lactobacillus plantarum ZY001, Lactobacillus rhamnosus, streptococcus thermophilus are prepared into fermentation with 1~3: 1~2: 1 proportioning
Seed, is seeded to donkey milk: milk=2~4: in 8~6 raw material, fermentation obtains donkey milk fermented dairy product.
Fermentation temperature described in step (2) is 42 DEG C, and fermentation termination is pH 4.0, i.e. curdled milk time；
Animal model every group 10, respectively blank group, saline control group, Lactobacillus plantarum described in step (3)
ZY001 acidified milks experimental group and the newborn group of mixing；Mode is given for gavage；Biochemical indicator blood is determined with automatic blood Biochemical Analyzer
The activity of glutamic-oxalacetic transaminease (AST) and glutamic-pyruvic transaminase (ALT) in clear.
The implementation of the present invention program, at least has the advantage that：
According to the inventive method, fermented bacterium is located away from the native bacterium fermentation donkey of the relatively low Kashi Area of Xingjiang Autonomous Region of the hepatopathy incidence of disease
Milk, animal experiment proves that, the bacterium has the liver function effect that has some improvement.One of application main material of the present invention is donkey milk,
Donkey milk has a strengthen immunity, beauty, effect of anti-aging, after being fermented through Lactobacillus plantarum ZY001, be more easy to be absorbed by the body,
Metabolism, fermented product possesses donkey milk and Lactobacillus plantarum ZY001 double effects.From this hair unlike the A of CN 106190930
The strain of bright offer is the strain for possessing independent intellectual property right voluntarily separated, has carried out Patent Deposit；With CN 104770469
A is compared, and the product that the present invention is provided is fermented milk products truly, in curdy.
Embodiment
Below in conjunction with specific embodiment, further the present invention is described in detail, so that the purpose of the present invention, technology
Scheme and advantage are clearer.Following examples are only used for for example, not constituting any limitation to the present invention.
Embodiment 1
Lactobacillus plantarum ZY001 be separated from the herdsman family natural fermented sourdough donkey milk of Xinjiang, filter out one plant have
The Lactobacillus plantarum of excellent fermentation character.By ZY001 streak inoculations to MRS agar mediums, 42 DEG C of culture 24h, in the condition
The lower generation of progress continuous passage culture 25, unknown significance variation.
Picking ZY001 bacterium colonies, setting-out is inoculated on MRS fluid nutrient mediums, is cultivated under conditions of 37 DEG C of temperature and anaerobism
48h；After bacterium colony is formed, it is inoculated with 1% inoculum concentration under the conditions of MRS fluid nutrient mediums, 37 DEG C and expands culture 24h；Draw again
Line is preserved on MRS agar mediums, confirming as puncturing after pure culture on MRS semisolid culturemediums at 4 DEG C.Observation
Colonial morphology, the Gram's staining cell morphological characteristic of pure culture are recorded, and carries out conventional catalase and oxidizing ferment experiment.
It is in that shaft-like bacterial strain temporary designations are breast by Gram-positive, catalase and oxidase test feminine gender and cellular morphology
Bacillus.The bacterial strain forms lurid circular colonies projection on MRS culture mediums, and surface is smooth, fine and closely woven, observes under the microscope
Cell be generally elongated rod-shaped.
The MRS agar mediums that the present invention is used close sulphur by 10g peptones, 10g beef extracts, 5g yeast extracts, 2g citric acids
The blue acetate hydrate of sour magnesium, 20g glucose, 1ml Tween 80s, 5g is received, the hypophosphite monohydrate hydrogen dipotassiums of 2g tri-, 0.58g bitter salts,
0.25g Manganous sulfate monohydrates, 6g agar and 1000ml distilled water are constituted, its pH 6.2-6.6.
The MRS fluid nutrient mediums that the present invention is used are by 10g peptones, 10g beef extracts, 5g yeast extracts, 2g hydrogen citrates
Diamines, 20g glucose, 1ml Tween 80s, the acetate hydrates of 5g tri- are received, the hypophosphite monohydrate hydrogen dipotassiums of 2g tri-, 0.58g bitter salts,
0.25g Manganous sulfate monohydrates are constituted with 1000ml distilled water, its pH 6.2-6.6.
In terms of MRS fluid nutrient medium weight 2% inoculum concentration, training is expanded by the strain isolated and purified under the conditions of 37 DEG C
Support, carbohydrate production sour (API50CH) is then carried out to microbial strain culture reacts, and identifies the physicochemical property of strain.
With kit extract strain DNA, design 16S rDNA and pheS gene orders primer go forward side by side performing PCR reaction and survey
Sequence.Compared by 16S rDNA and pheS gene homology, the bacterial strain and Lactobacillus plantarum
WCFS1(Sequence ID：NC_004567.2) there is 99% homology.By the comprehensive analysis to multinomial experimental data, mirror
Bacterial strain ZY001 is determined for Lactobacillus plantarum.
Table 1 is strain ZY001 cellular morphologies and Physiology and biochemistry qualification result.
Embodiment 2：
The Lactobacillus plantarum ZY001 of activation is inoculated in MRS fluid nutrient mediums, 37 DEG C of culture 24h are connect with 4% inoculum concentration
Plain chocolate is planted, 42 DEG C of quiescent cultures are to curdled milk, after being sufficiently stirred for, and take caseous fermentation liquid to be seeded to donkey milk with 4% inoculum concentration: milk
In=3: 7 mixing breast, 42 DEG C of cultures obtain Lactobacillus plantarum ZY001 acidified milks, the curdled milk time is 12h, during curdled milk to curdled milk
PH is 4.0.Obtaining the unfermentable mixing breast of Lactobacillus plantarum ZY001 acidified milks and configuration is used for follow-up zoopery.
Embodiment 3：Rat builds alcoholic liver injury model
40 SD rats (male and female half and half) machines are divided into model group and blank group, body weight 180-200g, in temperature 22-24
DEG C, humidity 30-40%, illumination and interlunation, Normal group was given as model group animal to be raised in 12h environment
Basal diet, model group presses the ethanol solution 12mL/kg*bw of the dosage gavage 50% of 0.2mL/100g weights, 1 time a day；
Normal group gives isometric distilled water, continues after 30 days, is determined with automatic blood Biochemical Analyzer in biochemical indicator serum
The activity of glutamic-oxalacetic transaminease (AST) and glutamic-pyruvic transaminase (ALT).Successful SD rats will be modeled to be grouped at random, every group 10, point
Wei not blank group, saline control group, Lactobacillus plantarum ZY001 acidified milks experimental group and the newborn group of mixing；It is filling to give mode
Stomach, gavage amount 5mL/ times, 2 times a day, and glutamic-oxalacetic transaminease in biochemical indicator serum is determined with automatic blood Biochemical Analyzer after 2 weeks
(AST) and glutamic-pyruvic transaminase (ALT) activity, the results are shown in Table 2.Found through zoopery, with single bacterium donkey milk acidified milk gavage second
Alcohol hepatic injury SD rats, can significantly improve AST and ALT expression, it can be seen that, Lactobacillus plantarum ZY001 possesses improvement liver function
Effect of energy.
Embodiment 4：The preparation of donkey milk acidified milk
With donkey milk and milk mixing breast for raw material, substrate proportioning 2: 8,3: 7,4: 6.Activation culture company early stage is preserved respectively
Three kinds of bacterium are cultivated 24h for 37 DEG C by Lactobacillus rhamnosus, streptococcus thermophilus and Lactobacillus plantarum ZY001 in MRS culture mediums
Afterwards, 4% it is inoculated in after sterile plain chocolate, 42 DEG C of quiescent culture to curdled milks by Lactobacillus plantarum ZY001, Lactobacillus rhamnosus and thermophilic
Hot streptococcus=1: 1: 1,1: 2: 1,2: 1: 1,2: 2: 1；3: 1: 1,3: 2: 1 various proportioning inoculation donkey milk milk mixing breasts (2-4:
8-6), 42 DEG C of quiescent cultures obtain the donkey milk fermented dairy product of different ratio to curdled milk.
The strain ZY001 cellular morphologies of table 1 and physical and chemical experiment result table
Note：+ represent negative reaction；
- represent negative reaction.
Fig. 1 strain ZY001 16SrDNA gene order sequencing results
ATACATGCAGTCGAACGAACTCTGGTATTGATTGGTGCTTGCATCATGATTTACATTTGAGTGAGTGGC
GAACTGGTGAGTAACACGTGGGAAACCTGCCCAGAAGCGGGGGATAACACCTGGAAACAGATGCTAATACCGCATAA
CAACTTGGACCGCATGGTCCGAGCTTGAAAGATGGCTTCGGCTATCACTTTTGGATGGTCCCGCGGCGTATTAGCTA
GATGGTGGGGTAACGGCTCACCATGGCAATGATACGTAGCCGACCTGAGAGGGTAATCGGCCACATTGGGACTGAGA
CACGGCCCAAACTCCTACGGGAGGCAGCAGTAGGGAATCTTCCACAATGGACGAAAGTCTGATGGAGCAACGCCGCG
TGAGTGAAGAAGGGTTTCGGCTCGTAAAACTCTGTTGTTAAAGAAGAACATATCTGAGAGTAACTGTTCAGGTATTG
ACGGTATTTAACCAGAAAGCCACGGCTAACTACGTGCCAGCAGCCGCGGTAATACGTAGGTGGCAAGCGTTGTCCGG
ATTTATTGGGCGTAAAGCGAGCGCAGGCGGTTTTTTAAGTCTGATGTGAAAGCCTTCGGCTCAACCGAAGAAGTGCA
TCGGAAACTGGGAAACTTGAGTGCAGAAGAGGACAGTGGAACTCCATGTGTAGCGGTGAAATGCGTAGATATATGGA
AGAACACCAGTGGCGAAGGCGGCTGTCTGGTCTGTAACTGACGCTGAGGCTCGAAAGTATGGGTAGCAAACAGGATT
AGATACCCTGGTAGTCCATACCGTAAACGATGAATGCTAAGTGTTGGAGGGTTTCCGCCCTTCAGTGCTGCAGCTAA
CGCATTAAGCATTCCGCCTGGGGAGTACGGCCGCAAGGCTGAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCGG
TGGAGCATGTGGTTTAATTCGAAGCTACGCGAAGAACCTTACCAGGTCTTGACATACTATGCAAATCTAAGAGATTA
GACGTTCCCTTCGGGGACATGGATACAGGTGGTGCATGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTC
CCGCAACGAGCGCAACCCTTATTATCAGTTGCCAGCATTAAGTTGGGCACTCTGGTGAGACTGCCGGTGACAAACCG
GAGGAAGGTGGGGATGACGTCAAATCATCATGCCCCTTATGACCTGGGCTACACACGTGCTACAATGGATGGTACAA
CGAGTTGCGAACTCGCGAGAGTAAGCTAATCTCTTAAAGCCATTCTCAGTTCGGATTGTAGGCTGCAACTCGCCTAC
ATGAAGTCGGAATCGCTAGTTATCGCGGATCAGCATGCCGCGGTGAATACGTTCCCGGGCCTTGTACACACCGCCCG
TCACACCATGAGAGTTTGTAACACCCAAAGTCGGTGGGGTAACCTTTTAGGAACCAGCCGCCTAAGGTGGGACAGAT
GATTAGGGTGAAGTCGTAACAAG
Fig. 2 strain ZY001 pheS gene order sequencing results
AAGACGTGCTACTACGCACGCAGACGTCTGCTGATCAGCCGCGGTCACTTGAAAATCACGATTTTTCTA
AAGGACCGCTGAAGGTCTTGTCACCTGGCCGCGTTTATCGGCGTGATACGGATGATGCAACCCATTCCCATCAATTT
CATCAAATTGAAGGGTTAGTCGTGGACAAGCATATTACGATGGCTGATTTGAAGGGCACCTTAATTCTGGTTGCCAA
GACTTTGTTTGGCGATCAATTCGAGTTTCGGCTACGGCCAAGCTTCTTTCCATTCACGGAACCATCCGTAGAAGCTG
ATGTAACTTGCTTTAATTGCAATGGCAAGGGCTGTGCAATCTCTAAGCAAACGGGTTGGATCGAAGTACTGGGTGCC
GGCATGGTTCACCCCCACGTGTTAGAAATGTCTGGCATTGATCCAGAAGAATATGGTGGCTTTGCTTTCGGGCCTAG
G
Enzyme index of the acidified milk of table 2 to alcoholic liver injury in rats model
| Group | AST(U/L) | ALT(U/L) |
| Normal group | 19.82±4.32 | 26.21±4.38 |
| Model group | 51.21±6.38 | 46.89±6.34 |
| Saline control group | 50.76±4.75 | 45.86±5.56 |
| The newborn group of mixing | 45.25±6.78 | 41.77±7.18 |
| Lactobacillus plantarum ZY001 acidified milk experimental groups | 36.53±6.75 | 36.45±6.17 |
Claims (6)
1. the Lactobacillus plantarum ZY001 (Lactobacillus plantarum, L.plantarum) of one plant of improvement liver function
ZY001, the bacterial strain is on 09 02nd, 2016 in Yard 1, BeiChen xi Road, Chaoyang District, Beijing City 3 Chinese Academy of Sciences microorganism
China Committee for Culture Collection of Microorganisms's common micro-organisms center of research institute preservation, its preserving number is CGMCC 13505.
2. Lactobacillus plantarum ZY001 according to claim 1, it is characterised in that the bacterium is located away from the new of region feature
The native bacterium of boundary donkey milk fermentation.
3. Lactobacillus plantarum ZY001 according to claim 1, it is characterised in that the bacterium can be used alone for fresh milk especially
It is the fermentation of donkey milk；Or include Lactobacillus rhamnosus, streptococcus thermophilus, Lactobacillus delbrueckii Asia with other lactic acid bacterias
Kind, lactobacillus paracasei, bifidobacterium longum etc. merge using the double bacterium of progress or many cooperative fermentation fresh milks especially donkey milk.
4. purposes according to claim 2, it is characterised in that the preparation method of the acidified milk is as follows：
(1) strain of preservation is inoculated in commercialization lactic acid bacteria culturing medium MRS inclined-planes, 37-38 DEG C of culture 24h by actication of culture；With
MRS fluid nutrient mediums, 37-38 DEG C of culture 24h are inoculated with afterwards；
(2) prepared by seed：140g/L skimmed milk powers are configured as seed fermentation culture medium, 115 DEG C of 15min that sterilize, after cooling, with
2-4% inoculum concentrations are inoculated with, 41-43 DEG C of culture 12h；
(3) ferment：By Lactobacillus plantarum ZY001 with 4% inoculum concentration, donkey milk is inoculated into: in milk=2-4: 8-6 raw material, 42
DEG C culture is to curdled milk state, pH3.8；Or by Lactobacillus plantarum ZY001, Lactobacillus rhamnosus, streptococcus thermophilus with 1-3: 1-2: 1
Proportioning prepares fermentation seed, and total inoculum concentration 3-6% is inoculated into donkey milk: in milk=1-2: 4-3 raw material, 42 DEG C are cultivated to solidifying
Emulsus state.
5. Lactobacillus plantarum ZY001 according to claim 1, it is characterised in that the bacterium possesses the effect for improving liver function.
6. fresh milk according to claim 2 includes fresh milk, mare's milk, goat milk, camel milk, donkey milk.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710376089.5A CN107151638B (en) | 2017-05-25 | 2017-05-25 | Lactobacillus plantarum ZY001 for improving liver function and application thereof in fermented milk |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710376089.5A CN107151638B (en) | 2017-05-25 | 2017-05-25 | Lactobacillus plantarum ZY001 for improving liver function and application thereof in fermented milk |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN107151638A true CN107151638A (en) | 2017-09-12 |
| CN107151638B CN107151638B (en) | 2020-05-08 |
Family
ID=59794118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710376089.5A Active CN107151638B (en) | 2017-05-25 | 2017-05-25 | Lactobacillus plantarum ZY001 for improving liver function and application thereof in fermented milk |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107151638B (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109619184A (en) * | 2018-12-29 | 2019-04-16 | 重庆第二师范学院 | Application of the lactobacillus plantarum CQPC02 in the food or drug of preparation prevention liver oxidative damage |
| CN110643524A (en) * | 2019-07-23 | 2020-01-03 | 广东益可维健康科技有限公司 | Composite probiotic preparation with gastrointestinal tract mucosa protection effect and application thereof |
| CN111543639A (en) * | 2019-02-11 | 2020-08-18 | 丰华生物科技股份有限公司 | Food composition and pharmaceutical composition containing lactic acid bacteria strain for protecting liver |
| CN114134089A (en) * | 2021-12-31 | 2022-03-04 | 内蒙古蒙牛乳业（集团）股份有限公司 | Composite microbial inoculum with high activity and application thereof in food production |
| CN115443328A (en) * | 2020-03-24 | 2022-12-06 | 玫帝托克斯股份有限公司 | Microorganism for improving liver function or inhibiting fat accumulation and use thereof |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20060062740A (en) * | 2004-12-06 | 2006-06-12 | 제주도(관리부서:제주도해양수산자원연구소) | Novel lactic acid bacteria strain for the production of fermented lactic acid bacteria of cactus, and method for producing the cactus fermented product using the same |
| CN102618456A (en) * | 2012-02-28 | 2012-08-01 | 江南大学 | Lactobacillus rhamnosus capable of relieving chronic alcohol liver injury and application thereof |
| CN102753701A (en) * | 2009-05-05 | 2012-10-24 | 优罗拉克提斯集团公司 | Probiotic microorganisms isolated from donkey milk |
| CN103734338A (en) * | 2013-12-18 | 2014-04-23 | 南昌大学 | Compounded donkey milk powder for improving immunity |
| CN106074623A (en) * | 2016-07-07 | 2016-11-09 | 吉林省农业科学院 | Lactobacillus plantarum application in preparation has the product of hepatoprotective function |
| CN106376645A (en) * | 2016-08-30 | 2017-02-08 | 新疆玉昆仑天然食品工程有限公司 | Freeze-dried yoghurt powder and manufacturing method thereof |
-
2017
- 2017-05-25 CN CN201710376089.5A patent/CN107151638B/en active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20060062740A (en) * | 2004-12-06 | 2006-06-12 | 제주도(관리부서:제주도해양수산자원연구소) | Novel lactic acid bacteria strain for the production of fermented lactic acid bacteria of cactus, and method for producing the cactus fermented product using the same |
| CN102753701A (en) * | 2009-05-05 | 2012-10-24 | 优罗拉克提斯集团公司 | Probiotic microorganisms isolated from donkey milk |
| CN102618456A (en) * | 2012-02-28 | 2012-08-01 | 江南大学 | Lactobacillus rhamnosus capable of relieving chronic alcohol liver injury and application thereof |
| CN103734338A (en) * | 2013-12-18 | 2014-04-23 | 南昌大学 | Compounded donkey milk powder for improving immunity |
| CN106074623A (en) * | 2016-07-07 | 2016-11-09 | 吉林省农业科学院 | Lactobacillus plantarum application in preparation has the product of hepatoprotective function |
| CN106376645A (en) * | 2016-08-30 | 2017-02-08 | 新疆玉昆仑天然食品工程有限公司 | Freeze-dried yoghurt powder and manufacturing method thereof |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109619184A (en) * | 2018-12-29 | 2019-04-16 | 重庆第二师范学院 | Application of the lactobacillus plantarum CQPC02 in the food or drug of preparation prevention liver oxidative damage |
| CN109619184B (en) * | 2018-12-29 | 2022-04-15 | 重庆第二师范学院 | Application of Lactobacillus plantarum CQPC02 in the preparation of medicines for preventing liver oxidative damage |
| CN111543639A (en) * | 2019-02-11 | 2020-08-18 | 丰华生物科技股份有限公司 | Food composition and pharmaceutical composition containing lactic acid bacteria strain for protecting liver |
| CN110643524A (en) * | 2019-07-23 | 2020-01-03 | 广东益可维健康科技有限公司 | Composite probiotic preparation with gastrointestinal tract mucosa protection effect and application thereof |
| CN110643524B (en) * | 2019-07-23 | 2022-12-06 | 广东益可维健康科技有限公司 | Composite probiotic preparation with gastrointestinal tract mucosa protection effect and application thereof |
| CN115443328A (en) * | 2020-03-24 | 2022-12-06 | 玫帝托克斯股份有限公司 | Microorganism for improving liver function or inhibiting fat accumulation and use thereof |
| CN115443328B (en) * | 2020-03-24 | 2024-08-02 | 玫帝托克斯股份有限公司 | Microorganism for improving liver function or inhibiting fat accumulation and use thereof |
| CN114134089A (en) * | 2021-12-31 | 2022-03-04 | 内蒙古蒙牛乳业（集团）股份有限公司 | Composite microbial inoculum with high activity and application thereof in food production |
| CN114134089B (en) * | 2021-12-31 | 2023-11-17 | 内蒙古蒙牛乳业（集团）股份有限公司 | Composite microbial agent with high activity and application thereof in food production |
Also Published As
| Publication number | Publication date |
|---|---|
| CN107151638B (en) | 2020-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104845912B (en) | One lactobacillus plantarum | |
| CN103937709B (en) | Lactobacillus paraceasi FM-LP-4 with acid resistance and high reducing activity and uses thereof | |
| CN107151638A (en) | One plant improvement liver function Lactobacillus plantarum ZY001 and its application in acidified milk | |
| CN106754619A (en) | It is a kind of that the method that traditional Chinese medicinal components promote growth of probiotics is added in grain culture medium | |
| CN109593683B (en) | Lactobacillus paracasei and application thereof | |
| CN104531587B (en) | One lactobacillus plantarum and its application in active fermentation breast | |
| CN110106119B (en) | Lactobacillus rhamnosus M9 separated from breast milk and application thereof | |
| CN105483050B (en) | One lactobacillus plantarum and its application in fermented feed | |
| CN111944712B (en) | A Lactobacillus plantarum with excellent alcohol tolerance and its application | |
| CN116286468A (en) | Lactobacillus mucilaginosus LF-ONLLY with antioxidant function and application thereof in fermented food | |
| CN109666599A (en) | A kind of lactobacillus reuteri high density fermentation culture medium and fermentation process, application | |
| CN110157650B (en) | Bifidobacterium lactis M8 separated from breast milk and application thereof | |
| CN103952336B (en) | Bacillus licheniformis, bacillus subtilis and lactobacillus casei preparation and preparation | |
| CN112126599B (en) | High-density culture method of lactobacillus helveticus, preparation of high-activity bacterium powder and application of high-density culture method | |
| CN103320337B (en) | Lactobacillus pentosus | |
| CN106497842A (en) | The preparation method and application of a kind of lactic acid bacteria and aspergillus niger mixed solid fermentation preparation | |
| CN103271155B (en) | Method for increasing viable count of probiotics | |
| CN104877940B (en) | One plant of streptococcus thermophilus | |
| CN109810917B (en) | Lactobacillus salivarius and its application | |
| CN110250464A (en) | A kind of preparation method of the Selenium-enriched fermentation phoenix head salty base of ginger | |
| CN1986775A (en) | Bacillus subtilis strain suitable for light fermented soybean pure-breed fermentation | |
| CN103966139A (en) | Lactobacillus brevis capable of producing gamma-aminobutyric acid at high yield in Sichuan pickle vegetables | |
| CN108504589A (en) | A kind of compound lactobacillus probiotics and its preparation method and application | |
| CN108283244A (en) | A kind of method of Cordyceps militaris solid state fermentation wheat bran | |
| CN108741087A (en) | A method of ferment is made by probiotics fermention plant cell fruit or organ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20240424 Address after: 102299 No. 9-9 Shuinan Road, Shuitunjiayuan, Changping Town, Changping District, Beijing Patentee after: Zhongyu (Beijing) Medical Research Institute Country or region after: China Address before: Room 302, Building A, Jingchen Building, No.1 Nanshatan A, Chaoyang District, Beijing, 100101 Patentee before: ZHONGYU (BEIJING) BIOLOGICAL ENGINEERING Co.,Ltd. Country or region before: China |
|
| TR01 | Transfer of patent right |